Skip to main content
OpenTrials
Completed

NCT Number: NCT04319445

Mindfulness During COVID-19

The objective of this study is to provide remote mindfulness session(s) to help during the COVID-19 pandemic.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Migraine Disorders Anxiety Anxiety Disorders Brain Diseases COVID-19 Central Nervous System Diseases Coronaviridae Infections Coronavirus Infections Headache Disorders Headache Disorders, Primary Infections Lung Diseases Mental Disorders Nervous System Diseases Nidovirales Infections Pneumonia Pneumonia, Viral RNA Virus Infections Respiratory Tract Diseases Respiratory Tract Infections Stress Virus Diseases

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Wake Forest Health Sciences

Winston-Salem, North Carolina, 27157, United States

About this study

The objective of this study is to provide remote mindfulness session(s) to help during the COVID-19 pandemic.The investigators are interested in targeting patients with migraine, providers, faculty and staff. The investigators are hopeful that this will positively impact overall well-being at this stressful time. The investigators are interested in assessing feasibility, accessibility, and overall interest of an online mindfulness intervention in these populations at this time.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Any person interested in participating in the mindfulness session will be eligible to complete the pre/post surveys and participate in the mindfulness session.

Exclusion criteria

  • None

Treatment and study plan

Mindfulness session(s)

Behavioral

The sessions will be hosted online using an online platform (such as through webex, private YouTube page, Facebook live, etc).

Primary outcomes

  1. Helpfulness of the Session

    Time frame: Post-Intervention (upon completion of session up to 15 minutes)

    Percentage of Participants who Felt the Mindfulness Session was Helpful - After the mindfulness session, participants used a Likert scale rating to respond to the question "How helpful was this session for you?"

  2. Platform Effectiveness

    Time frame: Post-Intervention (upon completion of session up to 15 minutes)

    Percentage of Participants who Perceived the Electronic Platform to be Effective for Practicing Mindfulness - After the mindfulness session, participants used a Likert scale rating to respond to the question "Did you find this electronic platform effective for practicing mindfulness?"

Secondary outcomes

  1. Change in Anxiety Level

    Time frame: Pre- Intervention, Post-Intervention (upon completion of session up to 15 minutes)

    Percentage of Participants With Reduction in Anxiety After Mindfulness Session - Before and after the mindfulness session, participants responded to the question, "At this moment, how anxious do you feel?"

  2. Change in Stress Level

    Time frame: Pre- Intervention, Post-Intervention (upon completion of session up to 15 minutes)

    Percentage of Participants With Reduction in Stress After Mindfulness Session - Before and after the mindfulness session, participants responded to the question, "At this moment, how much stress do you feel?"

  3. Value of the Session

    Time frame: Post-Intervention (upon completion of session up to 15 minutes)

    Percentage of Participants who Felt the Mindfulness Session was Valuable - After the mindfulness session, participants used a Likert scale rating to respond to the question "How much was the session of value to you?"

  4. Satisfaction With the Session

    Time frame: Post-Intervention (upon completion of session up to 15 minutes)

    Percentage of Participants who were Satisfied with the Mindfulness Session - After the mindfulness session, participants used a Likert scale rating to respond to the question "How satisfied are you with this experience?"

  5. Percentage of Participants That Showed Interest in a Future Session

    Time frame: Post-Intervention (upon completion of session up to 15 minutes)

    Percentage of participants that showed interest in a future session

  6. Percentage of Participants That Would Recommend This Session to a Family Member

    Time frame: Post-Intervention (upon completion of session up to 15 minutes)

    Percentage of participants that would recommend this session to a family member

  7. Percentage of Participants by Session Frequency Preference - Daily

    Time frame: Post-Intervention (upon completion of session up to 15 minutes)

    Percentage of participants that would prefer to participate in daily similar sessions again if offered

  8. Percentage of Participants by Session Frequency Preference - Weekly

    Time frame: Post-Intervention (upon completion of session up to 15 minutes)

    Percentage of participants that would prefer to participate in weekly similar sessions again if offered

  9. Percentage of Participants by Session Frequency Preference - Monthly

    Time frame: Post-Intervention (upon completion of session up to 15 minutes)

    Percentage of participants that would prefer to participate in monthly similar sessions again if offered

Other outcomes

  1. Decreased Concern Level About the COVID 19 Pandemic

    Time frame: Pre- Intervention, Post-Intervention (upon completion of session up to 15 minutes)

    Percent of Participants With Reduction in Concern over COVID-19 After Mindfulness Session - Before and after the mindfulness session, participants responded to the question, "At this moment, how concerned are you about the Coronavirus pandemic?"

Sponsors and collaborators

Lead sponsor

Wake Forest University Health Sciences

Other

Registry information

Official study title

Mindfulness During COVID-19 - Remote Mindfulness Sessions

Important dates

Study start
2020
Primary completion
2020
Study completion
2020
First posted
Mar 24, 2020
Registry last updated
Mar 2, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.